Press

In Memoriam: Phillip Parrish, Leader of Cross-University Research Initiatives

Phillip A. Parrish, interim vice president for research at the University of Virginia, died unexpectedly Wednesday evening. Parrish played a key role in the development of three new University-wide research institutes – the UVA Brain Institute, the Environmental Resilience Institute and the Global Infectious Diseases Institute – all part of a major initiative to distinguish the University through trans-disciplinary research and scholarship addressing areas of critical global societal need.

Read More

Clean water innovator seeks global market

Inside a local company’s production facility, about 15,000 tablets called MadiDrops are packed in boxes and stacked against a wall. Collectively, these tablets could provide safe water for 1,000 families for 8-15 years.

Read More

LVG 2016 Annual Report

Wondering what LVG has been up to? Our 2016 Annual Report is here! Enjoy stories about the compelling research taking place at UVA, and how the team at LVG is working to help shape their innovations toward commercialization.

Read More

UVA Innovator of the Year Teaches the Civic Duties of Science

Although he’s earned many titles and honors for his advancements in molecular research, Brooks Pate sees himself first as a citizen-scientist. The University of Virginia’s William R. Kenan Jr. Professor of Chemistry is committed to conducting basic research for the public good.

Read More

Melur K. Ramasubramanian Appointed UVA Vice President for Research

​Melur K. “Ram” Ramasubramanian has been appointed UVA’s vice president for research, University President Teresa A. Sullivan announced today. Ramasubramanian will assume this position on August 8 and will report to the President. He is currently program director for the Engineering Research Centers program at the National Science Foundation and D.W. Reynolds Distinguished Professor and department chair of Mechanical Engineering at Clemson University, with a joint faculty appointment as professor of bioengineering.

Read More

$2.5 Million Grant Targets Mysteries of Duchenne Muscular Dystrophy

Duchenne muscular dystrophy affects one in 3,500 boys, stealing their ability to walk by age 12 and typically killing them by their mid-20s. Doctors know what causes the muscle-wasting disease, but, frustratingly, experimental treatments consistently fail. University of Virginia researchers are out to change that, however, with the help of a $2.5 million grant from the National Institutes of Health.

Read More

Cavion hopes to grow and inspire with venture capital success

Cavion, a Charlottesville biopharmaceutical company, sent shockwaves through Virginia’s startup scene with a recent announcement that it had raised $26.1 million in Series A venture investment. Andrew Krouse, president and CEO of the company, said securing the funding will help Cavion to achieve a more important goal.

Read More

UVA Health System’s Dr. William A. Petri Named Virginia Outstanding Scientist

The University of Virginia Health System’s Dr. William A. Petri Jr. on Thursday was named one of Virginia’s Outstanding Scientists. The awards, recognizing three scientists who have made globally significant contributions to their fields, were announced by Gov. Terry McAuliffe and Richard C. Conti, chief wonder officer at the Science Museum of Virginia.

Read More

Cavion Raises $26.1 MM Series A Financing

Cavion, Inc., announced today the closing of a $26.1 million venture financing. Lilly Ventures and Novartis Venture Fund co-led the investment round in tandem with Enso Ventures and additional participation of existing investors. Cavion is a clinical stage biotechnology company developing T-type calcium channel (Cav3) modulators for the treatment of neurological diseases and cancer.

Read More

NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine Technologies from Tandem Diabetes Care, Dexcom and TypeZero

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc. (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, and TypeZero Technologies, LLC, a digital health and personalized medicine company, today announced that they are working together on the integration of their technologies into the NIH-funded International Diabetes Closed Loop (IDCL) Trial starting later this year.

Read More

In Memoriam: John C. Herr, Ph.D.

John C. Herr, 68, director of the University of Virginia’s Center for Research in Contraceptive and Reproductive Health, died unexpectedly on Saturday after having participated that morning in the Gene Arnold Memorial Special Olympics 10K Run & 2 Mile Walk at Meriwether Lewis Elementary School in Ivy.

Read More

HemoSonics' Groundbreaking System for the Management of Critical Bleeding Presented in Four Articles in Anesthesia & Analgesia

HemoSonics announced today the publication of four journal articles, accompanied by an editorial, in Anesthesia & Analgesia describing the first clinical experiences with the Quantra™ Hemostasis Analyzer, a groundbreaking system designed to transform and improve the management of critical bleeding. These papers introduce the device and describe the results of multi-center clinical studies involving more than 150 cardiac and spine surgery patients. The leading editorial highlights Quantra's novel SEER Sonorheometry technology, which may provide significant advantages over existing systems.

Read More

MSi Closes Third Financing to Help Protect Control Systems in Critical Defense and Industrial Assets

Mission Secure, Inc., (MSi) a provider of cyber protection solutions focused on control systems and critical assets in energy and defense, announced it has successfully closed a third round of financing. The funds will be used to expand MSi’s team and further enhance the company’s patent-pending Secure Sentinel Platform. The Secure Sentinel Platform protects control systems and the key processes they monitor and operate from cyber attacks.

Read More

MadiDrop Safe Water Technology Boosted by Bridge Funds

​MadiDrop PBC closed a second round of bridge funding with an investment from Axel Johnson Inc., a private operating company that invests in industry-leading businesses. The funds will help to build market share for safe drinking water technologies and to increase manufacturing at the company’s Virginia-based facility.

Read More

New Capital for Venture Capital

The National Venture Capital Association recently ranked Charlottesville as the fastest-growing venture capital ecosystem in the United States. Between 2010 and 2015, venture funding in Charlottesville jumped from $250,000 to $27.7 million invested in local companies, the organization said.

Read More

U.S Venture Capital Investment Spanned 133 MSAs in 2015: Charlottesville experienced the greatest rate of growth with a 156.5% increase since 2010

Measuring the compound annual growth rate (CAGR) of number of companies receiving venture capital funding since 2010, the Charlottesville, VA MSA has experienced the greatest growth of its ecosystem at 55.2 percent. Nine companies in the Charlottesville, VA MSA received $27.7 million in venture funding in 2015 compared to one company receiving $250,000 in 2010. Interestingly, the Charlottesville, VA MSA has also experienced the greatest rate of growth as measured by venture investment dollars with a 156.5 percent increase since 2010.

Read More

Agenus Acquires PhosImmune with a Novel Class of Cancer Neoantigens

​Agenus Inc. (NASDAQ: AGEN), an immunotherapy company developing innovative treatments for cancer, today announced that it has acquired privately-held PhosImmune Inc., a company that has discovered an entirely new portfolio of cancer neoantigens. The acquisition provides Agenus the ability to accelerate the development of new cancer vaccines and other single agent immuno-oncology approaches, as well as combination therapies.

Read More

Governor McAuliffe Announces New Funding for MACH37 Cyber Accelerator

​Governor Terry McAuliffe announced today a significant new public-private partnership that will speed the launch of new cybersecurity products and companies in Virginia, leading to new jobs and revenue. General Dynamics Mission Systems will now serve as a sponsor of the MACH37 Cyber Accelerator through an innovative funding and mentorship agreement.

Read More

Cavion LLC Closes $5M Round of Convertible Debt

​Cavion LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of neurologic diseases and solid tumor cancers, announced today that it has closed a $5 million private placement of convertible notes with new and existing investors. The proceeds will be used to expand Cavion’s platform of T-type calcium channel inhibitors through licensing and the development of new chemical entities and to support clinical trials in neurology and brain cancer. Cavion has raised over $18 million from private investors throughout the United States and received over $15 million in non-dilutive resources.

Read More

TearSolutions Raises $3M Series A Round to Advance the Treatment of Dry Eye

​TearSolutions LLC, a Charlottesville-based biotechnology company, has successfully closed its $3M Series A round with investments led by Santen Pharmaceuticals, Medarva Innovations LLC, the Center for Innovative Technology, and Launch Capital. The funds will enable the company to file an Investigational New Drug (IND) application in the second half of 2016 and initiate a Phase I/II clinical study.

Read More

RIVANNA Commences Sales of Accuro™ to Address Spinal Anesthesia

​Rivanna Medical announced today that it has begun selling its Accuro device to anesthesia providers as a result of a successful product launch at the annual meeting of the American Society of Anesthesiologists (ASA) in San Diego last week. The company also announced that it is continuing discussions with three potential corporate partners.

Read More

Biologist Uncovers Fundamental New Strategy for Destroying Cancer Cells

University of Virginia cell biologist John Herr believes that the most ground-breaking findings always start with an insight built on basic science. He would know; his steady research on the development of sperm and eggs has led to numerous breakthroughs in reproductive health, and now he believes his team has discovered a revolutionary strategy to treat cancer.

Read More

CIT Announces FY2016 Solicitation for Commonwealth Research Commercialization Fund

The CRCF grows Virginia’s economy by supporting high-potential technology commercialization projects at Virginia's public and private colleges and universities, the private sector, and nonprofit research institutions. A single solicitation for $3.4 million will be offered in FY2016, with five programs available for funding: Commercialization, SBIR Matching Funds, STTR Matching Funds, Matching Funds, and Eminent Researcher Recruitment.

Read More

UVA-Based Public Benefit Company To Provide Safe Drinking Water

A new University of Virginia-inspired public benefit company with a global health mission, MadiDrop PBC, has opened administrative offices and a small production facility in Charlottesville, company officials announced today at the 2015 Water and Health Conference, being held this week at the University of North Carolina’s School of Global Public Health.

Read More

Virginia Biosciences Health Research Corporation Awards over $2 Million to Fund Bioscience Research Initiatives

The Virginia Biosciences Health Research Corporation (VBHRC/“the catalyst”) today announced that it has awarded $2.23 million in grants to five collaborative bioscience commercialization projects between Virginia’s research universities and private companies. These awards arebeing matched by federal grants and/or direct industry contribution at an amount in excess of $5 million. Round four of funding is intended to catalyze the development and commercialization of life science projects that address major unmet needs for improving human health, while also contributing to Virginia’s economic growth.

Read More

TypeZero: Taking the Artificial Pancreas to the Next Level

UVA has partnered with facilities around the world from Stanford and UCSB to Europe and Israel, and talks are in the works with a site in Buenos Aires, Argentina. According to Dr. Daniel Chernavvsky, Assistant Professor of Research at the UVA Center for Diabetes Technology, a multi-center adult trial, AP@Home, will be completed here in the U.S. within the next couple of months. The European AP@Home is still underway. In addition to these trials and one like Kate did, trials for younger children will soon be starting at summer camps in France and Italy.

Read More

CaseNEX and Longleaf Solutions Join Forces Supported by New Investment from LLR Partners

CaseNEX and Longleaf Solutions, innovative leaders of data management and professional development solutions for the K-12 education market, today announced that the companies have merged, supported by a new investment from LLR Partners. Combining the companies’ highly complementary product portfolios, including BaselineEdge and DataCation, creates a leading provider of student data analytics, classroom management, teacher professional development and parent communication solutions. The integrated platform will enable teachers, school district administrators and parents to effectively monitor student achievement and address academic performance gaps.

Read More

Cell Surface Discovery May Lead to Major Breakthrough in Cancer Treatment

University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease. By more selectively targeting cancer cells, this method offers a strategy to reduce the length of and physical toll associated with current treatments.

Read More

CIT GAP Funds Invests in TypeZero Technologies

​The Center for Innovative Technology (CIT) announced today that its CIT GAP Funds has invested in TypeZero Technologies, LLC, an early-stage medical technology company with a proprietary intelligent control system that improves the safety, outcomes and quality of life for patients with Type 1 and Type 2 diabetes. CIT GAP Funds led TypeZero’s seed round, which included several other investors.

Read More

Three High-Profile Executives join U.Va. Licensing & Ventures Group Board of Directors

The University of Virginia Licensing & Ventures Group (LVG) is pleased to announce the addition of three high-profile executives and two additional high-level University administrators to its board of directors. Ron Newbold, Peter Barris, Michael Lenox, Phillip A. Parrish and Richard P. Shannon will join six other directors from a variety of industries as well as academia to assist LVG in long-range and strategic planning and to support LVG’s efforts to commercialize innovation assets.

Read More

Researchers Find Textbook-Altering Link Between Brain, Immune System

It’s a stunning discovery that overturns decades of textbook teaching: researchers at the School of Medicine have determined that the brain is directly connected to the immune system by vessels previously thought not to exist. “I really did not believe there were structures in the body that we were not aware of. I thought the body was mapped,” said Jonathan Kipnis, a professor in the Department of Neuroscience and director of the University’s Center for Brain Immunology and Glia. How these vessels could have escaped detection when the lymphatic system has been so thoroughly mapped throughout the body is surprising on its own.

Read More

Governor McAuliffe Announces Research Commercialization Awards

Governor Terry McAuliffe announced today 38 Commonwealth Research Commercialization Fund (CRCF) awards totaling more than $2.8 million to fund targeted areas of promising research and commercialization, including advanced manufacturing, cybersecurity, and energy and life sciences. Governor McAuliffe said, “The CRCF program advances research with potential for economic growth in Virginia."

Read More

UVA group to move into old Coca-Cola building

The University of Virginia Licensing and Ventures Group has agreed to lease 9,640 square feet of office space in the historic Preston Avenue building, joining a beer hall/restaurant and a bicycle shop in moving into the 76-year-old, 38,000-square-foot building.

Read More

U.Va.-UofM-UW Start-Up Announces NEA Venture Funding to Accelerate Energy-Efficient Wireless Technology

PsiKick, a company headquartered in Charlottesville and based on technology licensed from the University of Virginia, University of Michigan and University of Washington, announced a major financing milestone led by New Enterprise Associates (NEA), Osage University Partners and MINTS, a venture fund of the University of Michigan. This funding round will enable PsiKick to accelerate the development of the groundbreaking Ultra-Low-Power wireless sensing devices.

Read More

Universities build better futures

​More than half of today’s U.S. economic growth comes from innovation industries that barely existed 10 years ago. Intense global competition continues to create knowledge and new jobs in tomorrow’s industries. It’s why countries like India are investing billions to build 1,000 new universities in this decade, and it’s why U.S. states all invest in their own research universities.

Read More

U.Va. Innovation Launches Crowdfunding Site

U.Va. Innovation launched the University of Virginia’s first crowdfunding website this week, enabling alumni and others to make targeted, tax-deductible donations in support of specific research and development projects under way at the University.

Read More

Curry School’s Marcia Invernizzi is 2013 Innovator of the Year

For the first time, a representative from the Curry School of Education has taken the University of Virginia’s top innovation honor. U.Va. Innovation named Marcia A. Invernizzi the 2013 Edlich-Henderson Innovator of the Year in recognition of her work to improve children’s literacy. Invernizzi’s innovative Phonological Awareness Literacy Screening, or PALS, assessments and teaching tools are used in six countries and all 50 states to identify and provide customized learning experiences for young children at risk of becoming poor readers.

Read More

U.Va. Innovator Receives State’s Outstanding Faculty Award

​University of Virginia School of Medicine professor Dr. Erik Hewlett has received the state’s highest honor for college faculty. Hewlett, a professor of medicine, infectious diseases and international health at the School of Medicine, is one of only 12 educators selected by the State Council of Higher Education for Virginia to receive a 2013 Outstanding Faculty Award. The award recognizes accomplishments in teaching, research and public service.

Read More

Virginia Introduces Statewide Innovation Partnership with U.S. Department of Commerce

The University of Virginia will participate in a new statewide network designed to accelerate innovation and economic growth. One of only seven multi-institution initiatives to win federal funding as part of the U.S. Department of Commerce’s i6 Challenge in 2012, the Virginia Innovation Partnership will bring together universities, community colleges, corporations, investment capital and other resources to drive promising research discoveries forward.

Read More

U.Va. to Participate in 2012 BIO International Convention, Co-Sponsors the Translational Research Forum

Universities have historically been on the front lines of translating innovative research into novel medicines and technologies useful to patients. With that in mind, the 2012 BIO International Convention will look to highlight the role of academia in the advancement of the biotechnology field through the BIO Academic Park and the Translational Research Forum. Hosted by the Biotechnology Industry Organization (BIO), this year's global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA.

Read More

U.Va. Venture Summit: Turning Ideas Into Businesses

Technology and business ventures with ties to the University of Virginia will be pitched to an audience of investors from across the country, representing roughly $20 billion in active capital funds, at U.Va.'s fourth annual Venture Summit, being held April 19 in the Old Cabell Hall auditorium and April 20 in room 50 at the Darden School of Business.

Read More

'Serial Entrepreneur' Robin A. Felder Named U.Va. Innovator of the Year

U.Va. Innovation, a new initiative dedicated to maximizing the impact of University of Virginia research discoveries, has named Robin A. Felder its 2012 Edlich-Henderson Innovator of the Year. The highest honor bestowed on a U.Va. innovator, the award recognizes an individual or team each year whose research is making a "major impact."

Read More

ATCC-U.Va. Collaboration to Foster Biotech Discovery

ATCC, the premier biological materials resource and standards organization, and the University of Virginia, the commonwealth's flagship research university, have announced an innovative partnership to fund postdoctoral research in the biosciences.

Read More